Abstract

PurposeMapping brain hypoxia is a major goal for stroke diagnosis, pathophysiology and treatment monitoring. 18F-fluoro-misonidazole (FMISO) positron emission tomography (PET) is the gold standard hypoxia imaging method. Normobaric hyperoxia (NBO) is a promising therapy in acute stroke. In this pilot study, we tested the straightforward hypothesis that NBO would markedly reduce FMISO uptake in ischemic brain in Wistar and spontaneously hypertensive rats (SHRs), two rat strains with distinct vulnerability to brain ischemia, mimicking clinical heterogeneity.MethodsThirteen adult male rats were randomized to distal middle cerebral artery occlusion under either 30% O2 or 100% O2. FMISO was administered intravenously and PET data acquired dynamically for 3hrs, after which magnetic resonance imaging (MRI) and tetrazolium chloride (TTC) staining were carried out to map the ischemic lesion. Both FMISO tissue uptake at 2-3hrs and FMISO kinetic rate constants, determined based on previously published kinetic modelling, were obtained for the hypoxic area. In a separate group (n = 9), tissue oxygen partial pressure (PtO2) was measured in the ischemic tissue during both control and NBO conditions.ResultsAs expected, the FMISO PET, MRI and TTC lesion volumes were much larger in SHRs than Wistar rats in both the control and NBO conditions. NBO did not appear to substantially reduce FMISO lesion size, nor affect the FMISO kinetic rate constants in either strain. Likewise, MRI and TTC lesion volumes were unaffected. The parallel study showed the expected increases in ischemic cortex PtO2 under NBO, although these were small in some SHRs with very low baseline PtO2.ConclusionsDespite small samples, the apparent lack of marked effects of NBO on FMISO uptake suggests that in permanent ischemia the cellular mechanisms underlying FMISO trapping in hypoxic cells may be disjointed from PtO2. Better understanding of FMISO trapping processes will be important for future applications of FMISO imaging.

Highlights

  • Ischemic stroke is characterized by focal severe brain hypoxia

  • The FMISO positron emission tomography (PET), magnetic resonance imaging (MRI) and tetrazolium chloride (TTC) lesion volumes were much larger in spontaneously hypertensive rats (SHRs) than Wistar rats in both the control and Normobaric hyperoxia (NBO) conditions

  • The apparent lack of marked effects of NBO on FMISO uptake suggests that in permanent ischemia the cellular mechanisms underlying FMISO trapping in hypoxic cells may be disjointed from PtO2

Read more

Summary

Introduction

Ischemic stroke is characterized by focal severe brain hypoxia. In turn, tissue hypoxia triggers the cellular and molecular events that lead to infarction of the ‘ischemic penumbra’ unless perfusion—and oxygen delivery—is rapidly restored [1,2,3,4]. 18F-fluoro-misonidazole (FMISO) positron emission tomography (PET) is the gold standard in vivo hypoxia imaging method [5] and has been extensively used for stroke research in the last two decades both in rodents [6,7,8,9,10,11,12,13,14] and acute/subacute stroke patients [15,16,17,18,19,20,21,22,23,24]. The uptake of FMISO and other misonidazole derivatives depends on the presence of both severe tissue hypoxia and cell viability. With respect to the brain, it is highly sensitive to perfusion, and oxygen delivery, in rodent models of cerebral ischemia [14, 27, 28] as well as in human stroke [15]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call